|
|
Yale SPORE in Skin Cancer
|
5P50CA121974-05
|
$2,233,298
|
$1,339,979
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
$7,835
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
$7,997
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
$151,177
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
|
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia
|
5R37CA071692-14
|
$348,711
|
$87,178
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Wound Response Genes in Cancer Progression
|
5R01CA118750-04
|
$298,201
|
$298,201
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
|
Wnt-Dependent Neurite Outgrowth in Ewing Tumor Cells
|
ZIA BC 011224
|
$236,167
|
$70,850
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
|
Wnt antagonist genes in kidney tumor progression and metastasis
|
5R01CA130860-03
|
$625,454
|
$625,454
|
DAHIYA, RAJVIR
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
|
|
Wnt 7a and Its Role in EMT and Lung Cancer Metastasis
|
1R21CA153268-01
|
$191,365
|
$191,365
|
WINN, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Wine for Cancer-Associated Anorexia
|
5R01CA124614-04
|
$211,540
|
$211,540
|
JATOI, AMINAH
|
MAYO CLINIC
|
|
|
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
|
5R01CA095045-08
|
$277,229
|
$277,229
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Visualizing Immune Responses in vivo: a systems biology approach
|
5R21CA139168-02
|
$186,603
|
$46,651
|
Duda, Dan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-04
|
$1,082,298
|
$541,149
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
VEGF mRNA Expression Mechanisms in Hypoxia
|
5R01CA064436-14
|
$271,728
|
$271,728
|
CLAFFEY, KEVIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-22
|
$476,313
|
$476,313
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Vav3 Oncogene in Prostate Cancer
|
5R01CA119935-04
|
$266,760
|
$266,760
|
LU, SHAN
|
UNIVERSITY OF CINCINNATI
|
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
5R01CA103986-06
|
$254,023
|
$254,023
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-03
|
$1,500,000
|
$150,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
$14,143
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
$20,848
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$671,367
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Utility-Assessment for Co-Morbidities in Prostate Cancer
|
1R21CA137279-01A2
|
$212,392
|
$53,098
|
DALE, WILLIAM
|
UNIVERSITY OF CHICAGO
|
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
$215,971
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Uses of GEM models for Translational Cancer Research
|
5U01CA141508-02
|
$800,533
|
$800,533
|
CHIN, LYNDA
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$66,250
|
$46,375
|
Merlino, Glenn
|
CCR (NCI)
|
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$15,992
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$11,836
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$15,837
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$1,034,254
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Urokinase Receptor-initiated Cell-signaling
|
5R01CA094900-10
|
$267,850
|
$267,850
|
GONIAS, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Urokinase Receptor Integrin Interactions in Lung Cancer
|
5R01CA125564-04
|
$293,550
|
$293,550
|
CHAPMAN, HAROLD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-08S1
|
$200,000
|
$68,000
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-08S2
|
$225,768
|
$76,761
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096297-08
|
$1,543,594
|
$524,822
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096300-08
|
$1,243,985
|
$422,955
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S6
|
$1,444,105
|
$361,026
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S7
|
$98,815
|
$24,704
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
University of New Mexico Cancer Center Support
|
2P30CA118100-06
|
$2,035,899
|
$183,231
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S6
|
$99,994
|
$8,999
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S1
|
$39,736
|
$3,576
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S2
|
$100,055
|
$9,005
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S3
|
$199,946
|
$17,995
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S1
|
$100,000
|
$15,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-23
|
$5,994,681
|
$899,202
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-03S1
|
$91,667
|
$11,917
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-03
|
$1,463,613
|
$190,270
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-15S1
|
$99,999
|
$4,000
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-15
|
$1,304,625
|
$52,185
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
Underutilization of Surgical Resection in Patients with Pancreatic Cancer
|
5K07CA130983-03
|
$126,571
|
$126,571
|
Riall, Taylor
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
|
Understanding the RhoGDI2 metastasis suppressor gene
|
1R01CA143971-01
|
$402,559
|
$402,559
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Total relevant funding to Metastasis for this search: $385,223,790
|
